Copiktra Logo

The FIRST AND ONLY oral dual PI3K-δ and PI3K-γ inhibitor that predominantly targets malignant B cells and the tumor microenvironment1,2

COPIKTRA (duvelisib) is a kinase inhibitor indicated for the treatment of adult patients with1:

Please see full Prescribing Information including Boxed Warning.


Discover COPIKTRA
for CLL/SLL


Discover COPIKTRA
for FL